QMX-16125-34875

3 vaccinations 14 coded responses 24 check-ins 14 free-text entries 2 call cases

Sex: —
Age at first dose: 26-30
ZIP prefix: 152 / PA
Registered: 2021-04-04

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-01
Dose 1 — Pfizer-BioNTech
2021-04-04
Registered in v-safe
2021-04-04
Survey response — days 1–6 daily, dose 1
MedDRA: Lymph node pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Lymph node pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-05
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-06
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-08
Survey response — day 7, dose 1
MedDRA: Discomfort, Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Lymph node swelling/discomfort

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-22
Dose 2 — Pfizer-BioNTech
2021-04-22
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-24
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-29
Health check-in — day 7, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-05-26
Survey response — day 28, dose 2
MedDRA: Injection site pain — Feeling: Good

Free text: Pain at injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-12-07
Dose 3 — Moderna
2021-12-09
Survey response — days 1–6 daily, dose 3
MedDRA: Dyspnoea, Encephalitis, Heart rate increased, Heart rate irregular, Lymphadenopathy, Neuralgia — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Shortness of breath, neuralgia, encephalitis, lymphadenopathy, rapid/abnormal heartbeat

MedDRA releases: 2024-11 · check-in free text available
2021-12-12
Survey response — days 1–6 daily, dose 3
MedDRA: Brain fog, Chest discomfort, Dyspnoea, Exercise tolerance decreased, Lymphadenopathy — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Shortness of breath, lymphadenopathy, chest tightness, exercise intolerance, brain fog

MedDRA releases: 2024-11 · check-in free text available
2021-12-13
Survey response — days 1–6 daily, dose 3
MedDRA: Brain fog, Chest discomfort, Dyspnoea, Exercise tolerance decreased — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Shortness of breath, exercise intolerance, chest tightness, brain fog

MedDRA releases: 2024-11 · check-in free text available
2021-12-16
Survey response — day 7, dose 3
MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Lymphadenopathy

MedDRA releases: 2024-11 · check-in free text available
2021-12-16
Report sent to call center — day 7, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-17
Call 2 — Could Not Reach Participant
2021-12-23
Survey response — day 14, dose 3
MedDRA: Chills, Fatigue, Pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Fever increased to 101 after having decreased for a day or so. Chills worse at night. Fatigue & body aches remaining.

MedDRA releases: 2024-11 · check-in free text available
2021-12-30
Health check-in — day 21, dose 3
Feeling: Poor

Adult check-in
2022-01-04
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2022-01-11
Survey response — day 35, dose 3
MedDRA: Body temperature increased, Exercise tolerance decreased, Fatigue, Oropharyngeal pain, Poor quality sleep, Respiratory tract congestion, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sore throat, higher fever (100F) than last week, sneezing, congestion, fatigue, exercise intolerance, poor sleep quality.

MedDRA releases: 2024-11 · check-in free text available
2022-01-20
Survey response — day 42, dose 3
MedDRA: Body temperature increased, Chills, Fatigue, Lymphadenopathy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Fever each evening spiking to 100F, fatigue, chills, lymph node swelling

MedDRA releases: 2024-11 · check-in free text available
2022-06-07
Survey response — 6 months, dose 3
MedDRA: Post-acute COVID-19 syndrome, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: COVID-19 infection leading into post-COVID syndrome

MedDRA releases: 2024-11 · check-in free text available
2022-06-07
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-06-08
Call 1 — Left Voicemail
2022-06-08
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-01	Pfizer-BioNTech
2	2021-04-22	Pfizer-BioNTech
3	2021-12-07	Moderna	No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-04

Systemic reaction (other): Lymph node pain

Release 7 — day 7, dose 1

2021-04-08

Systemic reaction (other): Lymph node swelling/discomfort

Release 7 — days 1–6 daily, dose 2

2021-04-24

Systemic reaction (other): Lymphadenopathy

2021-04-25

Systemic reaction (other): Lymphadenopathy

Release 8 — days 1–6 daily, dose 2

2021-04-26

Systemic reaction (other): Lymphadenopathy

Release 8 — day 28, dose 2

2021-05-26

Symptoms: Pain at injection site

Release 10 — days 1–6 daily, dose 3

2021-12-09

Systemic reaction (other): Shortness of breath, neuralgia, encephalitis, lymphadenopathy, rapid/abnormal heartbeat

2021-12-12

Systemic reaction (other): Shortness of breath, lymphadenopathy, chest tightness, exercise intolerance, brain fog

2021-12-13

Systemic reaction (other): Shortness of breath, exercise intolerance, chest tightness, brain fog

Release 10 — day 7, dose 3

2021-12-16

Systemic reaction (other): Lymphadenopathy

Release 10 — day 14, dose 3

2021-12-23

Symptoms: Fever increased to 101 after having decreased for a day or so. Chills worse at night. Fatigue & body aches remaining.

Release 10 — day 35, dose 3

2022-01-11

Symptoms: Sore throat, higher fever (100F) than last week, sneezing, congestion, fatigue, exercise intolerance, poor sleep quality.

Release 10 — day 42, dose 3

2022-01-20

Symptoms: Fever each evening spiking to 100F, fatigue, chills, lymph node swelling

Release 11 — 6 months, dose 3

2022-06-07

Symptoms: COVID-19 infection leading into post-COVID syndrome

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Body temperature increased	·	·	✓
SD	Chills	·	·	✓
SD	Exercise tolerance decreased	·	·	✓
SD	Fatigue	·	·	✓
SD	Injection site pain	✓	✓	✓
SD	Lymphadenopathy	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	·	·	✓
SD	Poor quality sleep	·	·	✓
SD	Post-acute COVID-19 syndrome	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Sneezing	·	·	✓
SRO	Brain fog	·	·	✓
SRO	Chest discomfort	·	·	✓
SRO	Discomfort	✓	✓	✓
SRO	Dyspnoea	·	·	✓
SRO	Encephalitis	·	·	✓
SRO	Exercise tolerance decreased	·	·	✓
SRO	Heart rate increased	·	·	✓
SRO	Heart rate irregular	·	·	✓
SRO	Lymph node pain	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Neuralgia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release